Pharmaceutical Technology32m
Mazdutide by Eli Lilly and Co for Polycystic Ovarian Syndrome: Likelihood of Approval
Mazdutide is under clinical development by Eli Lilly and Co and currently in Phase II for Polycystic Ovarian Syndrome.
Pharmaceutical Technology56m
Tirzepatide by Eli Lilly and Co for Obesity: Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...